Predict your next investment

Corporation
HEALTHCARE | Drug Development
iconplc.com

See what CB Insights has to offer

Investments

1

Partners & Customers

10

Service Providers

1

About ICON

ICON (NASDAQ: ICLR) specializes in drug development for the pharmaceutical, biotechnology and medical device industries. The company specializes in the strategic development, management and analysis of programs that support clinical development from compound selection to Phase I-IV clinical studies.

ICON Headquarter Location

South County Business Park, Leopardstown

Dublin 18,

Ireland

+353 (1) 291 2000

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing ICON

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find ICON in 2 Expert Collections, including Clinical Trials Tech.

C

Clinical Trials Tech

329 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.

B

Biopharma Tech

326 items

Research containing ICON

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned ICON in 1 CB Insights research brief, most recently on Dec 14, 2020.

Latest ICON News

Health Economics and Outcomes Research (HEOR) Services Market Revenue to Cross $2.69Bn, Globally, by 2027 Growing at 11.9% CAGR | Exclusive Report by The Insight Partners

Aug 3, 2022

Market: Competitive Landscape and Key Developments Axtria, Inc.; Avalon Health Economics LLC; MEDLIOR; PHARMALEX GMBH; Analysis Group; ICON PLC; IQVIA Inc.; McKESSON CORPORATION; Syneos Health; and Optum, Inc. are among the leading companies operating in the healthcare economics and outcomes research (HEOR) services market. In Apr-2020, Axtria, Inc. announced expansion of its delivery centre in Bengaluru, India. The new centre is especially dedicated for big data analytics and development of cloud software in order to meet extensively increasing demand for healthcare analytics and information services. In Dec-2020, Syneos Health announced strategic collaboration with ConcertAI, one of the considerable players in real world evidence technology. The partnership is planning to implement novel oncology clinical trial research solutions with the help of artificial intelligence technologies. In Sep-2019, IQVIA Inc. joined DATA-CAN HDR, a UK based health digital data initiative. During this campaign, the company will deliver data-based solutions to improve the outcomes of cancer patients in NHS. In Dec-2019, PharmaLex entered into strategic partnership with Vintura. The new partnership will enable the company to consolidate its strategic consulting services for life science industry in Europe. Inquiry Before Purchase: https://www.theinsightpartners.com/inquiry/TIPRE00017816/ Health economics and outcomes research (HEOR) services play a significant role in drug approval and reimbursement with payers. The HEOR services allow to evaluate the economics of treatment and quantify the associated results. Likewise, in the healthcare industry, decision-makers experience the pressure to opt for therapeutic ‘interventions’ from various treatment options made available by pharmaceuticals, medical devices, and biotechnology companies. Also, there is constant pressure to control rising healthcare cost. Therefore, HEOR services help decision-makers to adequately compare and understand the appropriate option among all the available options. Growing Healthcare Spending to Drive Health Economics and Outcomes Research (HEOR) Services Market Growth Rise in disposable income, increase in awareness regarding technically advanced products and services, surge in demand for excellent healthcare services, and reimbursement policies and healthcare insurances are leading to increasing healthcare expenditure worldwide. According to the World Health Organization (WHO)'s report, “Public Spending on Health: A Closer Look at Global Trends,” published in 2016, ~US$ 7.5 trillion was spent on health. It is nearly 10% of the global gross domestic product (GDP). Similarly, according to WHO's updated report for 2018, “Public Spending on Health: A Closer Look at Global Trends,” the total healthcare spending is growing faster than GDP. It is increasing more rapidly in low and middle-income countries with an average of nearly 6% compared to high-income countries, which is ~4%. However, this spending can be saved by properly managing the money to avoid more spending on the 'waste domains,' such as failure of care, improper coordination, overtreatment or low-value care, pricing failure, fraud and abuse, and several administrative complexities. Organisation for Economic Co-operation and Development (OECD) is trying to figure out the minimum wastage of healthcare spending. According to an OECD report for 2017, “A significant share of health spending in OECD countries is at best ineffective and at worst, wasteful.” One-fifth of the total health spending can be properly channelized for efficient use. More than 9% of GDP is spent across the OECD countries, among which three quarters are paid for by governments. Such waste weakens the financial sustainability of health systems. Hence, financial sustainability requires proper management, and the money can be used by appropriate diagnosis and treatment planning to reduce the cost of healthcare services. Have a question? Speak to Research Analyst: https://www.theinsightpartners.com/speak-to-analyst/TIPRE00017816 The healthcare industry has a never-ending demand from its end users and consumers. It is a broad industry, which comprises pharmaceuticals, medical devices, and biotechnology. Therefore, there is a constant process of product development activities to provide quality products and improve lives worldwide. The other factors responsible for increasing product development are rising incidence of acute and chronic diseases, growing demand for minimally invasive treatments, rising healthcare expenditure, and evolving technologies. Advancing healthcare systems and increasing technological development have offered technologies, such as genomics, artificial intelligence, minimally invasive services, point-of-care services, and robotics treatments. Various factors, including regulation, cost, market-entry, profit/loss, and acceptance by end users and consumers, are associated with product development. Also, there is an increase in number of startups in the developed and developing regions. For instance, countries in North America, Europe, and Asia Pacific have registered various startups in the past two years, and during the COVID-19 pandemic, the number has risen significantly, resulting in increasing product developments. As these players are new to the market, they require proper guidance and understanding of the market; also, they need to outsource HEOR services. To save the cost of production, various well-established companies also outsource HEOR services. The HEOR service providers help pharmaceutical, biotechnology, and medical device companies explain the value of their innovations to their respective stakeholders, such as physicians, payers, and patients. Thus, due to increasing product development, there is growth in the demand for HEOR services, which is likely to continue in the coming future. Avail Lucrative DISCOUNTS on “Health Economics and Outcomes Research (HEOR) Services Market” Research Study: https://www.theinsightpartners.com/discount/TIPRE00017816/ Health Economics and Outcomes Research (HEOR) Services Market: Segmental Overview In terms of service, the healthcare economics and outcomes research (HEOR) services market is segmented into economic modelling/evaluation, real-world data analysis and information systems, clinical outcome, and market access solutions and reimbursement. The clinical outcome segment held the largest market share in 2019, and the real-world data analysis and information systems segment is estimated to register the highest CAGR during the forecast period. Based on service provider, the health economics and outcomes research (HEOR) services market is segmented into consultancy and contract research organization. In 2019, the contract research organization segment held larger share of the market, also, the same segment is estimated to register higher CAGR during 2020–2027. The health economics and outcomes research (HEOR) services market, by service provider, is segmented into consultancy and contract research organization. In 2019, the contract research organization segment held largest share of the market, also, the same segment is estimated to register higher CAGR during 2020-2027. Directly Purchase Premium Copy of Health Economics and Outcomes Research (HEOR) Services Market Growth Report at: https://www.theinsightpartners.com/buy/TIPRE00017816/ Browse Adjoining Reports:  Electronic Clinical Outcome Assessment Solutions Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Web-Hosted, Licensed Enterprises, and Cloud-Based); End User (Hospitals, CRO's, Academic Institutes, Pharma and Biotech Companies, and Medical Device Manufacturers), and Geography ePRO, ePatient Diaries, and eCOA Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type of Solution (ECOA (Electronic Clinical Outcome Assessments), EPROs (Patient Reported Outcomes), ClinROs (Clinician Reported Outcomes), ObsROs (Observer Reported Outcomes), PerfOs (Performance Outcomes), and ePatient Diaries); Modality (Computer, and Mobile Devices (Smartphones and Tablets)); End User (Clinical Trial Sponsors, Contract Research Organizations (CRO’s), Hospitals, Academic Institutes, Pharmaceutical Companies, and Others), and Geography Contract Research Organization Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Early Phase Development Services, Clinical Research Services, Laboratory Services, and Post-Approval Services) and End User (Pharmaceutical & Biotechnology Companies and Medical Device Companies) Healthcare Contract Research Organizations (CRO) Services Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Service Type (Early Phase Development, Laboratory Services, Consulting Services, Clinical Research Services); Therapeutic Indication (Oncology, Infectious Diseases, Respiratory Diseases, Cardiovascular Diseases, Neurological Disorders, Others); End User (Medical Device Companies, Pharmaceutical and Biopharmaceutical Companies, Others); and Geography IVD Contract Research Organization Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Clinical Chemistry, Molecular Diagnostics, Immunochemistry, Companion Diagnostics, Hematology, Histology & Cytology, Microbiology, and Others), Services (Clinical Research, Biostatistics & Data Management Services, Therapeutic Expertise, Regulatory Services, Reimbursement Support Services, Assay Development Services, and Others), and Geography Healthcare Payer Services Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Application (Integrated Front-End Services and Back-Office Operations, Provider Management Services, Analytics and Fraud Management Services, Billing and Accounts Management Services, HR Services, Claims Management Services); Service Type (Knowledge Process Outsourcing Services, Business Process Outsourcing Services, Information Technology Outsourcing Services); End User (Public Payers, Private Payers) and Geography About Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact Us: If you have any queries about this report or if you would like further information, please contact us: Contact Person: Sameer Joshi

ICON Investments

1 Investments

ICON has made 1 investments. Their latest investment was in Ping An Pay Electronic Payment as part of their Series C on August 8, 2005.

CBI Logo

ICON Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/1/2005

Series C

Ping An Pay Electronic Payment

$20M

Yes

1

Date

8/1/2005

Round

Series C

Company

Ping An Pay Electronic Payment

Amount

$20M

New?

Yes

Co-Investors

Sources

1

ICON Acquisitions

13 Acquisitions

ICON acquired 13 companies. Their latest acquisition was PRA Health Sciences on February 24, 2021.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

2/24/2021

Grant

$99M

Acq - P2P

12

2/19/2020

$99M

Acquired

1

10/23/2019

$99M

Acquired

2

5/23/2019

Subscribe to see more

$99M

Subscribe to see more

10

2/21/2019

Series D

Subscribe to see more

$99M

$99M

Subscribe to see more

10

Date

2/24/2021

2/19/2020

10/23/2019

5/23/2019

2/21/2019

Investment Stage

Grant

Series D

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$99M

Note

Acq - P2P

Acquired

Acquired

Subscribe to see more

Subscribe to see more

Sources

12

1

2

10

10

ICON Partners & Customers

10 Partners and customers

ICON has 10 strategic partners and customers. ICON recently partnered with Curebase on November 11, 2020.

Date

Type

Business Partner

Country

News Snippet

Sources

11/1/2020

Partner

United States

10/19/2020

Partner

United States

BARDA reselects ICON as preferred partner to help strengthen US emergency preparedness and response

We look forward to continuing to make our clinical expertise available to Biomedical Advanced Research and Development Authority partners as part of the Medical Countermeasures Clinical Studies Network . ''

1

9/18/2020

Partner

United States

7/22/2020

Vendor

Thailand

Subscribe to see more

Subscribe to see more

10

4/3/2020

Client

United States

Subscribe to see more

Subscribe to see more

10

Date

11/1/2020

10/19/2020

9/18/2020

7/22/2020

4/3/2020

Type

Partner

Partner

Partner

Vendor

Client

Business Partner

Country

United States

United States

United States

Thailand

United States

News Snippet

BARDA reselects ICON as preferred partner to help strengthen US emergency preparedness and response

We look forward to continuing to make our clinical expertise available to Biomedical Advanced Research and Development Authority partners as part of the Medical Countermeasures Clinical Studies Network . ''

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

ICON Service Providers

1 Service Provider

ICON has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Acquired

Investment Bank

Financial Advisor

Service Provider

Associated Rounds

Acquired

Provider Type

Investment Bank

Service Type

Financial Advisor

Partnership data by VentureSource

ICON Team

23 Team Members

ICON has 23 team members, including current President, Executive Vice President, Dana Poff.

Name

Work History

Title

Status

Dana Poff

President, Executive Vice President

Current

Lalit Pai

Senior Vice President

Current

Erik Leferink

Founder

Former

Bill Taaffe

Chief Executive Officer, President

Former

John W. Hubbard

President

Former

Name

Dana Poff

Lalit Pai

Erik Leferink

Bill Taaffe

John W. Hubbard

Work History

Title

President, Executive Vice President

Senior Vice President

Founder

Chief Executive Officer, President

President

Status

Current

Current

Former

Former

Former

You May Also Like

Vesta Healthcare Logo
Vesta Healthcare

Vesta Healthcare is a technology and clinical services organization, dedicated to connecting caregiver insights to the rest of the care team. Vesta Healthcare proactively identifies the need for additional support in the home and provides 24/7 telehealth support for caregivers and care recipients, with a focus on high-need, frail senior populations. Vesta partners with home care, health plans, and providers to create value-based population health programs that emphasize clinical quality, improved health outcomes, and personalized engagement. The company was founded in 2014 and is based in New York, New York.

Swift Medical Logo
Swift Medical

Swift Medical develops wound care management software. Swift Medical's mobile app captures wound care information. The company provides immediate tissue analytics using proprietary machine vision algorithms.

BioSerenity Logo
BioSerenity

BioSerenity develops wearable medical devices and digital point-of-care solutions, as well as electronic patient-reported outcome (ePRO), internet of things and cloud technologies.

AliveCor Logo
AliveCor

AliveCor focuses on the creation of FDA-cleared machine learning techniques to enable proactive heart care and is recognized around the world for transforming cardiac care. The FDA-cleared KardiaMobile is a clinically validated mobile EKG solution on the market. It is recommended by cardiologists and used by people worldwide for accurate EKG recordings. KardiaMobile, and KardiaBand, when paired with the Kardia app provide instant analysis for detecting atrial fibrillation (AF) and normal sinus rhythm in an EKG.

Qardio Logo
Qardio

Qardio offers remote blood pressure monitoring and 24 hour ambulatory recordings from a wireless device.

C
Cadence

Cadence offers a remote care management platform that enables clinicians to monitor patient vitals remotely, provide personalized feedback via text message after each reading, and conduct one-on-one telehealth visits when needed.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.